Institute of Tropical Medicine, Nagasaki University

Menu

The future depends on
good research.

Institute of Tropical Medicine,
Nagasaki University

slider image
slider image
slider image
slider image
slider image

Information

all information

Leptospirosis, an Overlooked Global Infectious Disease International collaborative team including Nagasaki University publishes a state-of-the-art clinical review in The Lancet Infectious Diseases. Co-authors from Nagasaki University included Professor Takeshi Tanaka, Professor Koya Ariyoshi, and Professor Chris Smith from the Institute of Tropical Medicine (NEKKEN) and the Tropical Medicine and Global Health (TMGH).

notification

details

'The 25th Nagasaki International Course on Research Ethics was held on June 10 - 12 at Pompe Hall in Sakamoto Campus, Nagasaki University. The registration deadline is May 20.

event

Website

Associate Professor Nobuo Saito of the Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, has received the 8th Tsutomu Takeuchi Memorial International Award from the Ohyama Health Foundation.

notification

details

An international research team led by Dr. Daniel Ken Inaoka has uncovered a unique biochemical mechanism that enables the parasitic worm Schistosoma mansoni to survive in sulfide-rich environments within the human body.

notification

details

An international research team led by Nagasaki University has elucidated, at the atomic level, the three-dimensional structure and reaction mechanism of the key energy-metabolism enzyme acetate: succinate CoA-transferase (ASCT) present in the mitochondria of Trypanosoma brucei (T. brucei), the protozoan parasite that causes African sleeping sickness (Human African trypanosomiasis).

notification

details

A research project led by Professor Daniel Ken Inaoka, in collaboration with Professor Yohei Doi of Fujita Health University, focusing on the development of a novel antibiotic with a new mechanism-of-action (MoA) against Klebsiella species (Klebsiella pneumoniae), has been selected to be part of the international research consortium Gram-Negative Antibiotic Discovery Innovator (Gr-ADI).

notification

details